
Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab, alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res. 2009, 24(1):153-161. doi: 10.1359/jbmr.080901.
Advertisement
Articles by Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab, alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res. 2009, 24(1):153-161. doi: 10.1359/jbmr.080901.

Advertisement
Latest Updated Articles
Study Summary: DECIDEJune 29th 2018
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Dexmedetomidine Sublingual Film as At-Home Agitation Therapy
2
Ribupatide Yields Up to 17.7% Weight Loss in Phase 3 GEMINI-1 Trial
3
GLP-1s Alone Won't Solve Obesity, JAMA Summit Report Says
4
Menopause Benefit Design Should Prioritize Access, Total Cost of Care
5